Is it more cost-effective for patients with chronic hepatitis b to have a trial of interferon before considering Nucleos(t)ide analogue therapy?

Clin Gastroenterol Hepatol. 2015 Feb;13(2):386-9. doi: 10.1016/j.cgh.2014.08.024. Epub 2014 Aug 23.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Cost-Benefit Analysis*
  • Drug Monitoring / methods*
  • Female
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / administration & dosage*
  • Male

Substances

  • Antiviral Agents
  • Interferon-alpha